About
Co-founded V-Bio Ventures in 2015 and serves as Managing Partner. She previously spent over 15 years in European venture capital, most recently as a partner at Forbion Capital Partners, and holds a PhD in developmental biology.
Experience
- V-Bio VenturesManaging Partnercurrent2015 — presentGent Area, Belgium
- Flindr TherapeuticsMember of The Supervisory Boardcurrent2024 — present
- Muna TherapeuticsBoard Observercurrent2021 — present
- PrecirixBoard Observercurrent2018 — presentBrussels Area, Belgium
- OXULAR LIMITEDMember of the Board2016 — 2024
- Confo TherapeuticsMember of the Board2016 — 2024
- OCTIMET Oncology NVMember of the Board2017 — 2024
- Syndesi TherapeuticsMember of the Board2017 — 2022Brussels Area, Belgium
- argenxBoard Director2009 — 2016Breda Area, Netherlands
- Independent advisor (life sciences)Consultant2015Amsterdam Area, Netherlands
- Pieris AGBoard Director2005 — 2015Munich Area, Germany
- Amakem NVBoard Director2011 — 2015Diepenbeek, Belgium
- Forbion Capital PartnersPartner2010 — 2015
- Forbion Capital PartnersPrincipal2007 — 2010
- ABN AMRO CapitalAssociate Director2000 — 2006
- Bio-Gen-Tec NRWBiotech Start Up Consultant2000
Education
- University of ColognePhD, Developmental Biology1995 — 1998
- Institut National de la Recherche Agronomique (INRA)Bachelor's degree, Developmental Biology1995
- Technische Universität DarmstadtDiplom, Biology1989 — 1995
- Université de Bordeaux IMaîtrise de la Physiologie Animale1993 — 1994
Skills & more
Strategy15Negotiation2Management5Venture Capital47Biotechnology44Start-ups34Lifesciences17Mergers & Acquisitions27Due Diligence15Drug Development10Technology Transfer9Corporate Development8
+12 more
Drug DiscoveryLicensingBusiness StrategyCommercializationVenture FinancingLife Science IndustryManagement ConsultingBusiness DevelopmentClinical TrialsBiopharmaceuticalsMedical DevicesPharmaceutical IndustryLanguages Dutch · English · French · German
From Christina's professional profile.
Same school
Also attended University of Cologne46
Andrea GazviniAssociate at NorthzoneJohann FriederichAssociate at Notion CapitalNicolas El BazeSenior Advisor at Partech VenturesMarkus MerzInvestment Manager at CapnamicDavid KuczekInvestor at HV CapitalAdrian FriederichPrincipal, Investment at FoodLabs
+ 40 more
Also attended Technische Universität Darmstadt15
Mathias FalcenbergVenture Partner at V-Bio VenturesThilo SchroederManaging Partner at Nextech InvestAlexander HuberCFO at UVC PartnersTheo WoikManaging Partner at C3 Venture CapitalHubertus MeineckeManaging Director & Senior Partner; Global Leader, Climate & Sustainability Practice at The Boston Consulting GroupTom KönigCTO at w3 fund
+ 9 more
Shared employers
Also worked at V-Bio Ventures5
Also worked at Flindr Therapeutics6
Mercedes TuinInvestment Director at BOMCédric Van NevelPartner at Qbic FundMariette van der VeldenPartner at Curie CapitalThom FrielinkAssociate at Curie CapitalGeert TackaertFinance Director at Bioqube VenturesFiona MacLaughlinVice President, Venture Investments at Johnson & Johnson Innovation – JJDC
Also worked at OXULAR LIMITED2
Colleagues at V-Bio Ventures
Aurelie Nowack
Principal at V-Bio Ventures
Charles Margarit
Associate at V-Bio Ventures
Dennis Pedri
Analyst at V-Bio Ventures
Dr. Loïc Laplanche
Chief Operating Officer at V-Bio Ventures
Dr. Marie-Laurence Gourlay-Chu
Chief Medical Officer at V-Bio Ventures
Katja Rosenkranz
Partner at V-Bio Ventures
Martin Solleveld
Finance Manager at V-Bio Ventures
Mathias Falcenberg
Venture Partner at V-Bio Ventures





:format(webp))























